Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Healing is a South Korean biotechnology company specializing in regenerative medicine and advanced cell therapies. The company focuses on developing innovative treatments for skin regeneration, musculoskeletal repair, and chronic wound management. Its core technology platform utilizes specialized cell culture techniques and biomaterials to promote tissue repair and rejuvenation. Bio-Healing's clinical pipeline includes BH-101, an autologous fibroblast therapy for skin wrinkles and scars, and BH-201, a chondrocyte-based therapy for cartilage defects. In addition to its therapeutic programs, the company commercializes a range of regenerative cosmetics and medical devices based on its proprietary biological research. Bio-Healing aims to address unmet medical needs in dermatology and orthopedics through its cell-based therapeutic approach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Healing.